When assessing the potential of clinical trials to accurately assess the role that GLP-1s may hold in treating MS, there are obstacles to consider, Shirani said
Gut Flora Changes : The introduction of semaglutide may alter the gut microbiome, which can contribute to gastrointestinal disturbances
Each batch undergoes strict quality control to ensure consistent, reliable results every time.
Eli Lilly has not announced a specific regulatory filing timeline
The product has been approved by the Central Drugs Standard Control Organization (CDSCO) following a multicentre, randomised, comparative, active-controlled, open-label Phase III clinical study conducted in India, demonstrating favourable efficacy and safety outcomes in Indian patients with Type 2 diabetes
Severe cases may involve pancreatitis or thyroid tumors